Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Sanofi - American Depositary Shares
(NQ:
SNY
)
42.99
+0.40 (+0.94%)
Streaming Delayed Price
Updated: 10:07 AM EDT, Sep 17, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Sanofi - American Depositary Shares
< Previous
1
2
...
28
29
30
31
32
33
34
35
36
...
42
43
Next >
Why Hill International Shares Are Trading Higher By 58%: Here Are 25 Stocks Moving Premarket
↗
August 17, 2022
Gainers Hill International, Inc. (NYSE: HIL) shares rose 58.1% to $2.75 in pre-market trading after the company agreed to be acquired by Global Infrastructure Solutions Inc. for $2.85 per share.
Via
Benzinga
Do I Need to Get A Polio Vaccine? New York Sewer Discovery Triggers Fears About Paralysis-Inducing Virus
↗
August 12, 2022
New York officials have detected polio in the city's wastewater, suggesting the virus has been circulating in the local area.
Via
Benzinga
Recalled Heartburn Pill Zantac Sets Fire To Glaxo and Sanofi Shares As Billions In Market Value Goes Up In Smoke
↗
August 11, 2022
Sanofi SA (NASDAQ: SNY), GSK Plc (NYSE: GSK), and Haleon Plc (NYSE: HLN) have lost a combined $40 billion in mar
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
↗
August 11, 2022
On Thursday, 22 companies reached new 52-week lows.
Via
Benzinga
Sanofi, Innovent Biologics Collaborate On Cancer Treatments In China
↗
August 04, 2022
Via
Benzinga
Sanofi Ekes Out Narrow Beat As Eczema Giant Scores Massive Gain
↗
July 28, 2022
The company reported more than 40% growth for Dupixent in the second quarter.
Via
Investor's Business Daily
GSK, PFE, SNY Stocks Fall on Zantac Litigation
↗
August 11, 2022
You may think safety concerns about Zantac from 2019 are old news now, but GSK stock traders and others are worried about the repercussions.
Via
InvestorPlace
Pharma Stocks GSK, Sanofi And Haleon Lose Billions As Zantac Trial Looms
↗
August 11, 2022
These companies are at the center of lawsuits claiming Zantac causes cancer.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
August 11, 2022
Via
Benzinga
Why Is Disney Higher By More Than 7%: Here Are 40 Stocks Moving Premarket
↗
August 11, 2022
Gainers
Via
Benzinga
Sanofi Raises Annual Guidance On Upbeat Q2 Performance
↗
July 28, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
↗
August 11, 2022
Good morning! We're starting off Thursday with an overview of the biggest pre-market stock movers that traders need to watch!
Via
InvestorPlace
Sonos, Bumble And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
↗
August 11, 2022
Via
Benzinga
WeTrade, Roblox And Some Other Big Stocks Moving Lower On Wednesday
↗
August 10, 2022
OptimizeRx Corporation (NASDAQ: OPRX) shares fell 26.7% to $16.32 after the company reported worse-than-expected Q2 EPS and sales results and issued FY22 sales guidance below estimates.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
↗
August 10, 2022
During Wednesday, 52 stocks hit new 52-week lows.
Via
Benzinga
Sanofi (NASDAQ:SNY) Shareholder Notice: Investigation Concerning Possible Violations of Securities Laws
↗
August 09, 2022
San Diego, CA -- (SBWIRE) -- 08/09/2022 -- Sanofi is under investigation over potential securities laws violations in connection with certain financial statements.
Via
SBWire
Monkeypox Plays Jockey For Position This Week
August 08, 2022
Via
AB Newswire
Looking Into Sanofi's Recent Short Interest
↗
August 04, 2022
Sanofi's (NASDAQ:SNY) short percent of float has fallen 25.0% since its last report. The company recently reported that it has 2.31 million shares sold short, which is 0.09% of...
Via
Benzinga
How Siga Is Turning Its Biowarfare Soldier Onto This Outbreak ... And The Next
↗
August 04, 2022
Siga stock more than tripled, emerging from under the radar to take on the outbreak.
Via
Investor's Business Daily
Regeneron's Prostate Cancer Combo Candidate Shows Encouraging Anti-Tumor Activity
↗
August 03, 2022
Via
Benzinga
A Bearish Sign Appears On Sanofi's Chart
↗
August 03, 2022
If history is any guide, there may be trouble ahead for shares of Sanofi (NASDAQ:SNY). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.
Via
Benzinga
Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial
↗
August 03, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
3-D Portfolio: Discounts, Diversification, And Dividends
↗
July 31, 2022
When it comes to high-yield closed-end funds, I’m a big fan of the “three Ds” — discounts, diversification, and dividends. Today, we’ll look at a three-fund, bargain-priced “3-D” CEF portfolio you can...
Via
Talk Markets
Week In Review: China Biopharma Tops $2.8 Billion In Week's Dealmaking
↗
July 30, 2022
CSPC Pharma out-licensed global rights for its antibody drug conjugate targeting Claudin18.2 to Elevation Oncology of New York City. CSPC will receive a $27 million upfront payment and up to $148...
Via
Talk Markets
Daily Biotech Pulse: GSK's Kidney Disease Drug Approved For Children, Tonix Pharma To Launch Monkeypox Vaccine Study In Kenya, Positive Effect Of Cyclerion's Schizophrenia Candidate
↗
July 28, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
A Monoclonal Antibody Treatment For ALS Could Begin Human Trials By 2023, According To Pasithea
↗
July 28, 2022
Pasithea Therapeutics Corp. (NASDAQ: KTTA), a biotech company looking for new treatments for psychiatric and neurological disorders, received an AU$1 million (US$694,000) gran
Via
Benzinga
Earnings Scheduled For July 28, 2022
↗
July 28, 2022
Companies Reporting Before The Bell • ArcelorMittal (NYSE:MT) is estimated to report earnings for its second quarter.
Via
Benzinga
Earnings Outlook For Sanofi
↗
July 27, 2022
Sanofi (NASDAQ:SNY) is set to give its latest quarterly earnings report on Thursday, 2022-07-28. Here's what investors need to know before the announcement. Analysts estimate that Sanofi will report an...
Via
Benzinga
Regeneron's Price Target Cut On Dim Prospects For Its Flagship Eye Product
↗
July 25, 2022
Via
Benzinga
Amid RNA Setbacks, Start Up Bets On Sanofi's siRNA Platform
↗
July 25, 2022
Via
Benzinga
< Previous
1
2
...
28
29
30
31
32
33
34
35
36
...
42
43
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
